Cytophage Technologies Company Description

Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name; and water-soluble solution for livestock producers under the FarmPhage name.

The company is headquartered in Winnipeg, Canada.

Cytophage Technologies Ltd.

Country	Canada
Industry	Biotechnology
Sector	Healthcare
CEO	Steven Theriault

Contact Details

Address: 26 Henlow Bay Winnipeg, Ontario R3Y1G4 Canada
Website	cytophage.com

Stock Details

Ticker Symbol	CYTO
Exchange	TSX Venture Exchange
Fiscal Year	January - December
Reporting Currency	CAD
SIC Code	2836

Key Executives

Name	Position
Dr. Steven Theriault B.Sc., M.Sc., Ph.D.	Chief Executive Officer, Chief Science Officer and Director
Julius John Kalcevich M.B.A.	Chief Financial Officer
Heather Medwick B.A.	Chief Operating Officer
Michael Graham M.B.A.	Chief Commercialization Officer